Evofem Biosciences, Inc. Earnings Per Share Diluted

Quick Answer

Evofem Biosciences, Inc. reported Earnings Per Share Diluted of $0.12 (loss) per share for the year ending 2024.

  • Evofem Biosciences, Inc. showed a decrease of -340.0% in Earnings Per Share Diluted from 2023 to 2024.
  • This data is from Evofem Biosciences, Inc.'s annual report (Form 10-K), filed with the SEC on March 24, 2025.
  • XBRL data for this metric is available from 2020 to 2024 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 5 years of available data (2020 to 2024), Evofem Biosciences, Inc.'s Earnings Per Share Diluted has grown by 94.3%.
  • Historical annual values: Fiscal year 2024: $0.12 (loss) per share | Fiscal year 2023: $0.05 per share | Fiscal year 2022: $167.42 (loss) per share | Fiscal year 2021: $23.63 (loss) per share | Fiscal year 2020: $2.12 (loss) per share.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: